VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Highlights in multiple myeloma at ASCO 2020

Thomas Martin, MD, of the Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, explores key presentations on multiple myeloma at ASCO 2020, including results from the ENDURANCE study (NCT01863550), comparing RVD and kRD, as well as updates in the Phase II KarMMa study (NCT03361748), and CARTITUDE-1 (NCT03548207), both BCMA targeting CAR-T cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter